Crohn’s disease, a chronic inflammatory bowel disease, has plagued humans for 25 years. The root cause of its repeated inflammation and intestinal damage has long been a medical puzzle. A team from UC San Diego, using AI combined with molecular biology, finally found the answer: the "molecular connection" between NOD2 and Guerdon proteins in gut immune cells is broken, causing the immune switch to malfunction and trigger persistent inflammation. This episode interprets this groundbreaking discovery and its significance for patients.

Key Findings

1. Core of Crohn’s: "Imbalance Between Offense and Defense" in Immune Cells
   In a healthy gut, immune cells called "macrophages" have two roles: "inflammatory type" attacks harmful bacteria, and "restorative type" repairs the gut after inflammation, maintaining a dynamic balance. In Crohn’s patients, this balance is disrupted—the "inflammatory type" macrophages remain active, causing constant inflammation even without threats, eventually damaging the intestinal wall.
2. Culprit: Disconnection Between NOD2 and Guerdon Proteins
   As early as 2001, scientists identified a common NOD2 gene mutation in Crohn’s patients but didn’t understand its pathogenic mechanism. New research shows: in a healthy state, the NOD2 protein (responsible for detecting bacterial invasions) binds to the Guerdon protein (responsible for organizing the cell’s internal structure), forming a "detection-repair" system that makes the immune response precise and efficient. However, patients have a deleted segment in the NOD2 gene, preventing it from binding to Guerdon. The system collapses, and immune cells fall into a "continuous attack" mode.
3. AI’s Critical Role: Identifying the Key from Massive Data
   The team collected thousands of macrophage gene profiles and needed to screen for differences among tens of thousands of genes—an impossible task for humans. Through machine learning, AI identified a "core set of 53 genes" that accurately distinguish between "inflammatory" and "restorative" macrophages, ultimately pinpointing the binding issue between NOD2 and Guerdon.
4. Animal Experiment Verification: Protein Disconnection Triggers Inflammation
   The team tested mice with Crohn’s-like symptoms: mice lacking Guerdon had far more severe gut inflammation than normal mice, disrupted gut microbiomes, and some even died of sepsis (total immune failure). This confirms that the binding of these two proteins is crucial for controlling inflammation.
5. New Treatment Direction: Precisely Repair the "Molecular Connection"
   Previous Crohn’s treatments mostly relied on broad-spectrum immunosuppressants with significant side effects. Now that the cause is clear, future therapies could include "molecular bridge" drugs to help mutated NOD2 rebind to Guerdon, or gene therapy to repair the deleted segment of the NOD2 gene—solving inflammation at the root instead of just relieving symptoms.

Summary

This discovery not only solves a 25-year medical puzzle but also advances Crohn’s treatment toward precision medicine. Curious about how AI analyzes gene data and the progress of new therapies? Tune in to this episode!